Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04807179 · ClinicalTrials.gov registry record · NA

Clinical Study to Evaluate Alexandrite Laser for the Treatment of Acne Scars

A NA study of Acne Scars, sponsored by Cynosure.

Active
Registry status
NA
Development phase
39
Enrollment target
2
Study locations

NCT04807179 is a NA study of Acne Scars that is active but no longer recruiting, run by Cynosure. The registered enrollment target is 39 participants, below the 80-participant average among 6 other Acne Scars trials with a reported enrollment target (51% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04807179, a NA study of Acne Scars, is active but no longer recruiting, sponsored by Cynosure.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
39 participants
Enrollment target
2
Study locations

Study Summary

The intended use of the Alexandrite laser device used in this study is to assess the efficacy and safety of the Alexandrite laser device for the treatment of acne scars on skin types V and VI.

Conditions Studied

Interventions

  • DEVICE Experimental: RF Device Arm

Study Locations (2)

California

  • Wallace Skin and Body Institute - Los Angeles

New York

  • Laser & Skin Surgery Center of New York - New York

Trial Details

FieldValue
Enrollment Target 39 participants
Start Date 2021-03-08
Est. Completion 2024-08-02
Phase NA

Sponsor

Cynosure

49 total trials

What the Registry Record Tells You About NCT04807179

The ClinicalTrials.gov registry entry for NCT04807179 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 80-participant average among 6 other Acne Scars trials with a reported enrollment target (51% lower). The listed sponsor is Cynosure, which has 49 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Acne Scars appearing as the primary indexed condition, and to 1 intervention - of which Experimental: RF Device Arm is the first listed.

NCT04807179 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, New York.

Frequently Asked Questions

What is clinical trial NCT04807179 about?

NCT04807179 is a clinical study titled "Clinical Study to Evaluate Alexandrite Laser for the Treatment of Acne Scars". The intended use of the Alexandrite laser device used in this study is to assess the efficacy and safety of the Alexandrite laser device for the treatment of acne scars on skin types V and VI.

What is the current status of trial NCT04807179?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 39 participants. The study started on 2021-03-08. Estimated completion is 2024-08-02.

What conditions does trial NCT04807179 study?

This clinical trial studies the following conditions: Acne Scars.

What interventions are being tested in trial NCT04807179?

The interventions under investigation include: Experimental: RF Device Arm (DEVICE).

Who is sponsoring clinical trial NCT04807179?

This trial is sponsored by Cynosure, which has 49 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04807179 being conducted?

This trial has 2 study locations across California, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Acne Scars

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.